Skip to main navigation Skip to search Skip to main content

Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation

  • Muneo Yamaguchi
  • , Shintaro Nakao*
  • , Mitsuru Arima
  • , Karis Little
  • , Aditi Singh
  • , Iori Wada
  • , Yoshihiro Kaizu
  • , Souska Zandi
  • , Justus G. Garweg
  • , Tetsuya Matoba
  • , Wataru Shiraishi
  • , Ryo Yamasaki
  • , Kensuke Shibata
  • , Yasuhiro Go
  • , Tatsuro Ishibashi
  • , Akiyoshi Uemura
  • , Alan W. Stitt
  • , Koh-Hei Sonoda
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Aims/hypothesis
Diabetic retinopathy is characterised by neuroinflammation that drives neuronal and vascular degenerative pathology, which in many individuals can lead to retinal ischaemia and neovascularisation. Infiltrating macrophages and activated retina-resident microglia have been implicated in the progression of diabetic retinopathy, although the distinct roles of these immune cells remain ill-defined. Our aim was to clarify the distinct roles of macrophages/microglia in the pathogenesis of proliferative ischaemic retinopathies.

Methods
Murine oxygen-induced retinopathy is commonly used as a model of ischaemia-induced proliferative diabetic retinopathy (PDR). We evaluated the phenotype macrophages/microglia by immunostaining, quantitative real-time RT-PCR (qRT-PCR), flow cytometry and scRNA-seq analysis. In clinical imaging studies of diabetic retinopathy, we used optical coherence tomography (OCT) and OCT angiography.

Results
Immunostaining, qRT-PCR and flow cytometry showed expression levels of M1-like macrophages/microglia markers (CD80, CD68 and nitric oxide synthase 2) and M2-like macrophages/microglia markers (CD206, CD163 and macrophage scavenger receptor 1) were upregulated in areas of retinal ischaemia and around neo-vessels, respectively. scRNA-seq analysis of the ischaemic retina revealed distinct ischaemia-related clusters of macrophages/microglia that express M1 markers as well as C-C chemokine receptor 2. Inhibition of Rho-kinase (ROCK) suppressed CCL2 expression and reduced CCR2-positive M1-like macrophages/microglia in areas of ischaemia. Furthermore, the area of retinal ischaemia was reduced by suppressing blood macrophage infiltration not only by ROCK inhibitor and monocyte chemoattractant protein-1 antibody but also by GdCl3. Clinical imaging studies of diabetic retinopathy using OCT indicated potential involvement of macrophages/microglia represented by hyperreflective foci in areas of reduced perfusion.

Conclusions/interpretation
These results collectively indicated that heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation in retinal vascular diseases including diabetic retinopathy. This adds important new information that could provide a basis for a more targeted, cell-specific therapeutic approach to prevent progression to sight-threatening PDR.

Original languageEnglish
Pages (from-to)2329–2345
Number of pages17
JournalDiabetologia
Volume67
Issue number10
Early online date08 Jul 2024
DOIs
Publication statusPublished - Oct 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • diabetic ischaemia
  • ischaemic retinopathy
  • macrophage polarisation
  • microglia
  • monocyte

Fingerprint

Dive into the research topics of 'Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation'. Together they form a unique fingerprint.

Cite this